The Patent Finder

Paratek Pharmaceuticals, Inc.

20 patents currently held · Updated Nov 18, 2026
1 more in force is now held by another company
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.

Recorded under 3 name spellings.

12
Ending by 2030
Dec 2027
Next term end

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 1 fee due Jan 14, 2027
    The maintenance fee for Methods of increasing oral bioavailability of tetracyclines (US 9,078,811) comes due Jan 14, 2027. Unpaid by Jul 14, 2027, it lapses early.
  • 1 fee due Feb 20, 2027
    The maintenance fee for 9-Aminomethyl Minocycline Compounds And Use Thereof In Treating Community-Acquired Bacterial Pneumonia (CABP) (US 10,383,884) comes due Feb 20, 2027. Unpaid by Aug 20, 2027, it lapses early.
  • 1 fee due Jul 5, 2027
    The maintenance fee for Salts and Polymorphs of a Tetracycline Compound (US 9,227,921) comes due Jul 5, 2027. Unpaid by Jan 5, 2028, it lapses early.
  • 1 fee due Aug 23, 2027
    The maintenance fee for Minocycline Compounds and Methods of Use Thereof (US 9,265,740) comes due Aug 23, 2027. Unpaid by Feb 23, 2028, it lapses early.
  • 1 fee due Oct 19, 2027
    The maintenance fee for Oral and Injectable Formulations of Tetracycline Compounds (US 9,314,475) comes due Oct 19, 2027. Unpaid by Apr 19, 2028, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

Nothing was recorded against this company's patents in the last 90 days.

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
PatentTitleStatus Expires Confidence
US 9,012,433Substituted Tetracycline Compounds
In force
 · Medium confidence
In forceMedium confidence
US 8,946,196Methods for Synthesizing and Purifying Aminoalkyl Tetracycline Compounds
In force
 · Medium confidence
In forceMedium confidence
US 9,434,680Methods for Synthesizing and Purifying Aminoalkyl Tetracycline Compounds
In force
 · High confidence
In forceHigh confidence
US 8,318,706Substituted Tetracycline Compounds
In force
 · Medium confidence
In forceMedium confidence
US 9,481,639Substituted tetracycline compounds for treatment of inflammatory skin disorders
In force
 · Medium confidence
In forceMedium confidence
US 9,724,358Minocycline Compounds and Methods of Use Thereof
In force
 · High confidence
In forceHigh confidence
US 10,124,014Minocycline Compounds and Methods of Use Thereof
In force
 · High confidence
In forceHigh confidence
US 8,513,223Substituted Tetracycline Compounds for Treatment of Inflammatory Skin Disorders
In force
 · High confidence
In forceHigh confidence
US 9,227,921Salts and Polymorphs of a Tetracycline Compound
In force
 · High confidence
In forceHigh confidence
US 9,078,811Methods of increasing oral bioavailability of tetracyclines
In force
 · High confidence
In forceHigh confidence
10 of 20 patents shown.
Pro members see all 20.
Pro members: see all 20 patents
Also on record, not counted in the 20: 1 patent in force now held by others · 37 lapsed for an unpaid fee · 21 ended at full term. List them

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

9 pending · 39 abandoned · 31 no status recorded

List them

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited